Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 145.46B KRW in the quarter ending September 30, 2025, a decrease of -6.73%. This brings the company's revenue in the last twelve months to 575.66B, down -5.67% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.

Revenue (ttm)

575.66B

Revenue Growth

-5.67%

P/S Ratio

1.69

Revenue / Employee

542.56M

Employees

1,061

Market Cap

972.02B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chong Kun Dang Pharmaceutical	1,680.99B
Daewoong	2,055.93B
DongKook Pharmaceutical	894.93B
Boryung	1,028.99B
Huons Global	825.44B
JW Pharmaceutical	764.21B
Dong-A Socio Holdings	1,404.83B
GC Biopharma	1,934.38B

Revenue Rankings